Richard E. Chaisson

42.3k total citations · 7 hit papers
370 papers, 28.4k citations indexed

About

Richard E. Chaisson is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Richard E. Chaisson has authored 370 papers receiving a total of 28.4k indexed citations (citations by other indexed papers that have themselves been cited), including 306 papers in Infectious Diseases, 235 papers in Epidemiology and 71 papers in Virology. Recurrent topics in Richard E. Chaisson's work include Tuberculosis Research and Epidemiology (201 papers), Pneumocystis jirovecii pneumonia detection and treatment (150 papers) and HIV/AIDS Research and Interventions (100 papers). Richard E. Chaisson is often cited by papers focused on Tuberculosis Research and Epidemiology (201 papers), Pneumocystis jirovecii pneumonia detection and treatment (150 papers) and HIV/AIDS Research and Interventions (100 papers). Richard E. Chaisson collaborates with scholars based in United States, South Africa and United Kingdom. Richard E. Chaisson's co-authors include Richard D. Moore, Gregory M. Lucas, Jeanne Keruly, Joel E. Gallant, Kelly E. Dooley, Jean B. Nachega, Neil Martinson, Thomas C. Quinn, Karen Chadwick and Theodore C. Pierson and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Richard E. Chaisson

360 papers receiving 27.2k citations

Hit Papers

Identification of a Reservoir for HIV-1 in Patients on Hi... 1989 2026 2001 2013 1997 1999 1999 2009 2011 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
    1997 2.4k citations Richard E. Chaisson et al. profile →
  2. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
    1999 1.6k citations Richard E. Chaisson et al. profile →
  3. Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions
    1999 701 citations Richard E. Chaisson, Richard D. Moore et al. profile →
  4. Tuberculosis and diabetes mellitus: convergence of two epidemics
    2009 687 citations Kelly E. Dooley, Richard E. Chaisson The Lancet Infectious Diseases profile →
  5. Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
    2011 630 citations Timothy R. Sterling, Margarita E. Villarino et al. New England Journal of Medicine profile →
  6. Cocaine Use and HIV Infection in Intravenous Drug Users in San Francisco
    1989 523 citations Richard E. Chaisson profile →
  7. Latent Mycobacterium tuberculosis Infection
    2015 515 citations Haileyesus Getahun, Alberto Matteelli et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard E. Chaisson United States 87 21.7k 15.6k 8.2k 4.9k 2.2k 370 28.4k
Henry Masur United States 88 10.4k 0.5× 17.4k 1.1× 6.1k 0.7× 3.4k 0.7× 5.1k 2.3× 375 33.5k
Diane V. Havlir United States 68 15.6k 0.7× 6.8k 0.4× 11.7k 1.4× 1.2k 0.2× 3.0k 1.4× 390 22.3k
Scott D. Holmberg United States 73 14.4k 0.7× 13.5k 0.9× 7.3k 0.9× 1.6k 0.3× 1.2k 0.6× 200 26.9k
Brian Gazzard United Kingdom 77 12.2k 0.6× 7.0k 0.5× 8.9k 1.1× 1.6k 0.3× 2.4k 1.1× 494 21.8k
Richard D. Moore United States 93 16.3k 0.8× 12.3k 0.8× 6.4k 0.8× 1.5k 0.3× 618 0.3× 635 30.6k
Andrew Phillips United Kingdom 81 18.5k 0.9× 8.2k 0.5× 12.3k 1.5× 1.3k 0.3× 1.2k 0.6× 563 27.6k
Caroline Sabin United Kingdom 85 15.7k 0.7× 9.9k 0.6× 10.2k 1.2× 2.5k 0.5× 1.3k 0.6× 611 28.0k
Margaret A. Fischl United States 62 16.5k 0.8× 6.8k 0.4× 12.5k 1.5× 762 0.2× 2.0k 0.9× 268 23.5k
Amalio Telenti Switzerland 86 15.3k 0.7× 9.3k 0.6× 8.7k 1.1× 2.2k 0.5× 3.0k 1.4× 355 27.0k
Michael S. Saag United States 84 19.4k 0.9× 9.5k 0.6× 15.5k 1.9× 679 0.1× 3.7k 1.7× 328 28.8k

Countries citing papers authored by Richard E. Chaisson

Since Specialization
Citations

This map shows the geographic impact of Richard E. Chaisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Chaisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Chaisson more than expected).

Fields of papers citing papers by Richard E. Chaisson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Chaisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Chaisson. The network helps show where Richard E. Chaisson may publish in the future.

Co-authorship network of co-authors of Richard E. Chaisson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Chaisson. A scholar is included among the top collaborators of Richard E. Chaisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Chaisson. Richard E. Chaisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mave, Vidya, Mandar Paradkar, Francesca Conradie, et al.. (2025). Tuberculosis disease among people with HIV: therapeutic advances. The Lancet HIV. 12(5). e367–e381.
2.
Kinikar, Aarti, Bharat Randive, S. K. Mattoo, et al.. (2024). 3HP preventive treatment among children and adolescents with HIV and child household contacts of TB patients. SHILAP Revista de lepidopterología. 1(9). 413–417. 1 indexed citations
3.
Winters, Nicholas, Robert Belknap, Andrea Benedetti, et al.. (2023). Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis. The Lancet Respiratory Medicine. 11(9). 782–790. 12 indexed citations
4.
Adu-Gyamfi, Clement Gascua, Dana Savulescu, Kennedy Otwombe, et al.. (2021). Plasma Kynurenine-to-Tryptophan Ratio, a Highly Sensitive Blood-Based Diagnostic Tool for Tuberculosis in Pregnant Women Living With Human Immunodeficiency Virus (HIV). Clinical Infectious Diseases. 73(6). 1027–1036. 14 indexed citations
5.
Rickman, Hannah M., Sylvia Cohn, Ziyaad Waja, et al.. (2020). Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV. The International Journal of Tuberculosis and Lung Disease. 24(7). 681–685. 7 indexed citations
6.
Chaisson, Lelia H., Valéria Saraceni, Silvia Cohn, et al.. (2019). CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV. AIDS. 34(1). 139–147. 6 indexed citations
7.
Getahun, Haileyesus, Alberto Matteelli, Richard E. Chaisson, & Mario Raviǵlione. (2015). Latent Mycobacterium tuberculosis Infection. New England Journal of Medicine. 372(22). 2127–2135. 515 indexed citations breakdown →
8.
9.
Dierberg, Kerry & Richard E. Chaisson. (2013). Human Immunodeficiency Virus–Associated Tuberculosis. Clinics in Chest Medicine. 34(2). 217–228. 15 indexed citations
10.
Shapiro, Adrienne E., et al.. (2012). Community-based Targeted Case Finding for Tuberculosis and HIV in Household Contacts of Patients with Tuberculosis in South Africa. American Journal of Respiratory and Critical Care Medicine. 185(10). 1110–1116. 87 indexed citations
11.
Churchyard, Gavin, Katherine Fielding, Stanzi M. le Roux, et al.. (2010). Twelve-monthly versus six-monthly radiological screening for active case-finding of tuberculosis: a randomised controlled trial. Thorax. 66(2). 134–139. 23 indexed citations
12.
Dorman, Susan E., John L. Johnson, Stefan Goldberg, et al.. (2009). Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 180(3). 273–280. 184 indexed citations
13.
Burman, William J., Stefan Goldberg, John L. Johnson, et al.. (2006). Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 174(3). 331–338. 207 indexed citations
14.
Karakousis, Petros C., Richard D. Moore, & Richard E. Chaisson. (2004). Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. The Lancet Infectious Diseases. 4(9). 557–565. 149 indexed citations
15.
Nuermberger, Eric L., Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.. (2003). Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 169(3). 421–426. 242 indexed citations
16.
Riley, Elise D., Richard E. Chaisson, Theodore J. Robnett, et al.. (2001). Use of Audio Computer-assisted Self-Interviews to Assess Tuberculosis-related Risk Behaviors. American Journal of Respiratory and Critical Care Medicine. 164(1). 82–85. 25 indexed citations
17.
Moore, Richard D., et al.. (2000). Effect of Antiretroviral Therapy on the Incidence of Bacterial Pneumonia in Patients with Advanced HIV Infection. American Journal of Respiratory and Critical Care Medicine. 162(1). 64–67. 82 indexed citations
18.
Corbett, Elizabeth L., Lucille Blumberg, Gavin Churchyard, et al.. (1999). Nontuberculous Mycobacteria: Defining Disease in a Prospective Cohort of South African Miners. American Journal of Respiratory and Critical Care Medicine. 160(1). 15–21. 82 indexed citations
19.
Kunin, C. M., Fred M. Gordin, P. R. Philips, Michael L. Tapper, & Richard E. Chaisson. (1996). Antimicrobial activity of rifabutin. Discussion. Clinical Infectious Diseases. 22. 1 indexed citations
20.
Barbacci, Marguerite, Richard E. Chaisson, & J. T. Repke. (1991). Routine prenatal screening for HIV infection. The Lancet. 337(8743). 709–711. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henry Masur Breakdown of academic impact, for papers by Diane V. Havlir Breakdown of academic impact, for papers by Scott D. Holmberg Breakdown of academic impact, for papers by Brian Gazzard Breakdown of academic impact, for papers by Richard D. Moore Breakdown of academic impact, for papers by Andrew Phillips Breakdown of academic impact, for papers by Caroline Sabin Breakdown of academic impact, for papers by Margaret A. Fischl Breakdown of academic impact, for papers by Amalio Telenti Breakdown of academic impact, for papers by Michael S. Saag
Rankless by CCL
2026